Artificial Intelligence In Diabetes Management Market Size, Share & Trends Analysis Report By Generic Drug (Glasdegib, Sonidegib, Vismodegib), By Dosage (Capsule and Injection), By End User (Homecare, Hospitals, Specialty Clinics), By Region, And By Segment Forecasts, 2025-2034

Global Artificial Intelligence In Diabetes Management Market is valued at USD 13.8 Bn in 2024 and is predicted to reach USD 32.4 Bn by the year 2034 at a 10.6% CAGR during the forecast period for 2025-2034. 

Artificial intelligence in diabetes management describes medical devices that observe, analyze, and treat diabetes remotely. The biological condition known as diabetes raises sugar levels in the circulatory system. The digital treatment of diabetes includes utilising software-driven systems, apps, and gadgets, including injection pens, detectors, closed-loop techniques, insulin updates, and smart glucose meters. This absorbed strategy addresses the difficulty of managing diabetes in a population that is becoming more and more common by facilitating better choice-making and treatment coordination.

The demand for diabetes management platforms is growing significantly due to technological improvements. The industry for diabetes management platforms is expanding as a result of the growing emphasis on individualized therapy. The requirement for platforms that provide individualized solutions is being driven by patients' growing need for therapies that are specifically designed to meet their demands.

However, one of the biggest issues when using AI to control diabetes is data security and privacy. In medical treatment, artificial intelligence relies significantly on tailored patient data, such as lifestyle characteristics, genealogy data, and private health records. For AI systems to produce precise forecasts and treatment suggestions, this type of data must be gathered and analyzed. However, because this data is so sensitive, it is vulnerable to cyberattacks and breaches, which might seriously jeopardize patient privacy. Additionally, worries regarding patient data privacy and a lack of knowledge about digital diabetes treatment are impeding market expansion in underdeveloped nations.

Some major key players in the artificial intelligence in diabetes management market:

• Vodafone Group PLC
• Apple Inc
• Google Inc
• International Business Machines Corporation (IBM)
• Glooko Inc
• Tidepool Inc

Market Segmentation:

The artificial intelligence in diabetes management market is segmented based on device and technique. Based on the device, the market is segmented into diagnostic devices, glucose monitoring devices, and insulin delivery devices. By technique, the market is segmented into case-based reasoning and intelligent data analysis.

Based on the Device, the Insulin Delivery Devices Segment is Accounted as a Major Contributor to the Artificial Intelligence in Diabetes Management Market 

Insulin delivery devices are expected to hold a major global market share in 2021 in the artificial intelligence in diabetes management market. These devices provide accurate insulin administration, lowering the chance of bradycardia and enhancing glucose regulation in general. More patients choose robots over manual techniques as insulin delivery system technology improves and becomes highly accessible and efficient. The use of intelligent insulin delivery systems is being further accelerated by their progress, which integrates with online resources for remote oversight and analysis.

Intelligent Data Analysis Segment to Witness Growth at a Rapid Rate

The intelligent data analysis segment is growing in the artificial intelligence market for diabetes management because diabetic individuals create so much data—including lifestyle information, medical records, and glucose levels—that it takes sophisticated analytical methods to glean helpful insights. Additionally, as AI algorithms and machine learning methods progress, data analysis becomes more precise and effective, propelling intelligent data analysis systems in diabetes management.

In The Region, The North American Artificial Intelligence In Diabetes Management Market Holds A Significant Revenue Share

The North American artificial intelligence in the diabetes management market is expected to register the highest market share in revenue shortly. This can be attributed to the region's established leading companies and the rising incidence of diabetes. Another factor contributing to the region's dominance in this sector is the existence of reputable artificial intelligence firms. Due to the combination of these variables, North America is leading the worldwide demand for artificial intelligence in diabetes management. In addition, the Asia Pacific is expected to grow rapidly in the artificial intelligence in diabetes management market owing to an increasing proportion of people with the disease, rising medical expenses, and more knowledge about how to treat the disease. Furthermore, government programs that encourage diabetes control, increased financial resources, and improved medical facilities contribute to the market's acceleration.

Competitive Landscape

The key players in the artificial intelligence in diabetes management market have shifted their focus toward technological advancement and higher demand for them. They are initiating significant strategies, such as mergers and joint ventures of major and domestic players, to expand their selection of products and raise their global market footprint. Some of the major key players in the artificial intelligence in diabetes management market are Vodafone Group PLC, Apple Inc, Google Inc, International Business Machines Corporation (IBM), Glooko Inc, and Tidepool Inc.

 Artificial Intelligence In Diabetes Management Market Report Scope:

Segmentation of Artificial Intelligence in Diabetes Management Market -

By Device

• Diagnostic Devices
• Glucose Monitoring Devices
• Insulin Delivery Devices

By Technique

• Case-Based Reasoning
• Intelligent Data Analysis

By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa-

• GCC Countries
• South Africa
• Rest of the Middle East and Africa